It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
White adipose tissue (WAT) plays a role in storing energy, while brown adipose tissue (BAT) is instrumental in the re-distribution of stored energy when dietary sources are unavailable. Interleukin-18 (IL18) is a cytokine playing a role in T-cell polarization, but also for regulating energy homeostasis via the dimeric IL18 receptor (IL18r) and Na-Cl co-transporter (NCC) on adipocytes. Here we show that IL18 signaling in metabolism is regulated at the level of receptor utilization, with preferential role for NCC in brown adipose tissue (BAT) and dominantly via IL18r in WAT. In Il18r−/−Ncc−/− mice, high-fat diet (HFD) causes more prominent body weight gain and insulin resistance than in wild-type mice. The WAT insulin resistance phenotype of the double-knockout mice is recapitulated in HFD-fed Il18r−/− mice, whereas decreased thermogenesis in BAT upon HFD is dependent on NCC deletion. BAT-selective depletion of either NCC or IL18 reduces thermogenesis and increases BAT and WAT inflammation. IL18r deletion in WAT reduces insulin signaling and increases WAT inflammation. In summary, our study contributes to the mechanistic understanding of IL18 regulation of energy metabolism and shows clearly discernible roles for its two receptors in brown and white adipose tissues.
Interleukin-18 (IL18) has a pivotal role in interferon signalling and T cell development, but increasingly recognized as an adipokine that regulates energy metabolism in fat tissue. Authors here dissect the function of IL18 signalling in the adipose compartment by targeted genomic deletion of its two receptors individually and in combination in brown and white adipose tissues.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Hefei University of Technology, School of Food and Biological Engineering, Hefei, China (GRID:grid.256896.6) (ISNI:0000 0001 0395 8562); Brigham and Women’s Hospital and Harvard Medical School, Department of Medicine, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
2 Brigham and Women’s Hospital and Harvard Medical School, Department of Medicine, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Department of Cardiology, Guangdong Cardiovascular Institute, Guangzhou, China (GRID:grid.413405.7) (ISNI:0000 0004 1808 0686)
3 Brigham and Women’s Hospital and Harvard Medical School, Department of Medicine, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
4 Hefei University of Technology, School of Food and Biological Engineering, Hefei, China (GRID:grid.256896.6) (ISNI:0000 0001 0395 8562)
5 Brigham and Women’s Hospital and Harvard Medical School, Department of Medicine, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Department of Nephrology, the First Affiliated Hospital, Research Institute of Nephrology, Zhengzhou University, Henan Province Research Center For Kidney Disease, Zhengzhou, China (GRID:grid.207374.5) (ISNI:0000 0001 2189 3846)
6 Yale School of Medicine, Department of Immunobiology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
7 Harvard School of Public Health, Department of Molecular Metabolism, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
8 Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Department of Nephrology, the First Affiliated Hospital, Research Institute of Nephrology, Zhengzhou University, Henan Province Research Center For Kidney Disease, Zhengzhou, China (GRID:grid.207374.5) (ISNI:0000 0001 2189 3846)